Huperzine A: Dietary Supplements For Brain Health

Aus Vokipedia
Wechseln zu: Navigation, Suche


Huperzine A is a chemical compound that may be isolated from the plant Huperzia serrata (Chinese club moss), a traditional Chinese treatment used for contusions, strains, swelling, and schizophrenia. It will also be made in a laboratory. Huperzine A is usually listed as "Huperzia serrata extract," "HupA," or "Chinese membership moss" on dietary supplement product labels. It is often marketed for Mind Guard product page well being and cognitive efficiency, with claims of enhanced brain power, reminiscence, alertness, attention, concentration, and focus. No dependable scientific proof helps the use of huperzine A to boost cognitive performance. Multi-ingredient merchandise containing huperzine A could be unsafe. Is it an authorized dietary complement ingredient? Although it is marketed in the U.S. A is an authorized drug in another nations. For example, huperzine A is out there in most hospitals in China and is used to "treat" Alzheimer’s illness. Within the U.S., nevertheless, it is unclear whether huperzine A may be legally marketed as a dietary supplement. Is huperzine A effective as a dietary complement?



To this point, no research have shown huperzine A to boost cognitive efficiency in in any other case wholesome individuals. Preliminary proof suggests huperzine might need beneficial results on cognitive function amongst Alzheimer’s illness patients, but more analysis is needed to ascertain this conclusively. Some firms have been advertising and marketing "supplements" containing huperzine A with illegal claims that their products can "treat" Alzheimer’s. Is huperzine A secure as a dietary supplement? Currently, the Alzheimer’s Association recommends not taking huperzine A, especially with prescription drugs, as a result of the mixture might increase the risk of severe unwanted effects. Taking huperzine A together with other dietary supplement components (especially ones marketed as nootropics) may pose further well being risks. Overall, security knowledge is lacking and long-term use will not be nicely understood. As well as, multi-ingredient products containing huperzine A have been shown to include various amounts of huperzine A inconsistent with the Supplement Facts label, as well as ingredients not allowed in dietary supplements.



Can Military Service Members use huperzine A? Huperzine A isn't prohibited for use by DoD members, and it will not trigger a constructive end result on a routine navy drug test. However, given the restricted evidence of its security, we advise warning with merchandise that contain this ingredient. In addition, some dietary complement merchandise containing huperzine A embody substances prohibited for use. Consuming such components might put your health, profession, or each at risk. In some circumstances, these components might not be listed on a product’s label, so you may eat prohibited components unknowingly. Using merchandise that have been third-party certified can allow you to keep away from this chance. Bridwell, R. E., Yoo, M. J., Grove, J. J., & Ng, P. C. (2020). Chest ache from complement use in an lively obligation soldier: A case report. Military Medicine, 185(9-10), e1857-e1859. Hao, Z., Liu, M., Liu, Z., & Lu, D. (2009). Huperzine A for vascular dementia.



Cochrane Database of Systematic Reviews, 2009(2), Article CD007365. Huang, P., Li, B., Guo, Y.-H., Feng, S., Hu, J., & Liu, Q.-Q. 2019). Efficacy and safety of huperzine A in treating patients with mild cognitive impairment: A scientific overview and meta-analysis (in Chinese). Jędrejko, K., Catlin, O., Stewart, T., Anderson, A., Muszyńska, B., & Catlin, D. H. (2023). Unauthorized substances in "nootropic" dietary supplements: A evaluate of the history, pharmacology, prevalence, worldwide laws, and potential as doping agents. Li, J., Wu, H. M., Zhou, R. L., Liu, G. J., Dong, B. R., & Wu, H. M. (2008). Huperzine A for Alzheimer's disease. Cochrane Database of Systematic Reviews, 2008(2), Article CD005592. Morasch, K. C., Aaron, C. L., Moon, J. E., & Gordon, R. K. (2015). Physiological and neurobehavioral effects of cholinesterase inhibition in healthy adults. Rafii, M. S., Walsh, S., Little, J. T., Behan, K., Reynolds, B., Ward, C., . Aisen, P. S. (2011). A part II trial of huperzine A in mild to moderate Alzheimer illness.



Tucker, J., Fischer, T., Upjohn, L., Mazzera, D., & Kumar, M. (2018). Unapproved pharmaceutical ingredients included in dietary supplements related to U.S. Food and Drug Administration warnings. JAMA Network Open, 1(6), Article e183337. U. S. Food & Drug Administration. 2019). FDA takes action towards 17 companies for illegally selling merchandise claiming to deal with Alzheimer’s disease. U.S. Food & Drug Administration. 2023). CFSAN adversarial occasion reporting system (CAERS). Wessinger, C. M., Inman, C. L., Mind Guard product page Weinstock, J., & Weiss, E. P. (2021). Effect of huperzine A on cognitive perform and perception of effort during train: A randomized double-blind crossover trial. Yang, G., Wang, Y., Tian, J., & Liu, J.-P. 2013). Huperzine A for Alzheimer’s disease: A systematic overview and meta-analysis of randomized clinical trials. PLoS ONE, 8(9), Article e74916. Yue, J., Dong, B. R., Lin, X., Yang, M., Wu, H. M., & Wu, T. (2012). Huperzine A for mild cognitive impairment. Cochrane Database of Systematic Reviews, 2012(12), Article CD008827.

Meine Werkzeuge
Namensräume

Varianten
Aktionen
Navigation
Werkzeuge